P-279 Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia

Results

Title:	P-279 Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia
Authors:	Spasic, Jelena ; Stanic, Nemanja; Ristic, Marija; Djordjevic, Feđa; Nikolic, Neda ; Nikolić, Vladimir ; Pupovac, S.; Radosavljević, Davorin
Issue Date:	2015
Publication:	ANNALS OF ONCOLOGY. ESMO- 2015 European Society for Medical Oncology. Abstracts/ Posters.
ISSN:	0923-7534 Annals of Oncology Search Idenfier
Publisher:	ESMO. European Society Medical Oncologists, Elsevier.
Type:	Conference Paper
Collation:	vol. 26 str. iv82-iv82
DOI:	10.1093/annonc/mdv233.276
URI:	https://enauka.gov.rs/handle/123456789/483830
URL:	https://www.annalsofoncology.org/article/S0923-7534(19)50809-2/fulltext https://www.annalsofoncology.org/action/showPdf?pii=S0923-7534%2819%2950809-2
Metadata source:	Migrirano iz RIS podataka
M-category:	Mp. category will be shown later

Altmetric

Dimensions

Unpaywall

Google Scholar^TM